An<i>ex vivo</i>evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose

Abstract

In the absence of surgical-related haemostatic disturbances and based on target ACT levels under reduced- or full-dose heparin, the clotting process was similar to heparin-coated and new sulphonated polymer-coated ECC, both demonstrating similar thromboresistance.